Klein Christine, Krainc Dimitri, Schlossmacher Michael G, Lang Anthony E
Section of Clinical and Molecular Neurogenetics, Department of Neurology, University of Lübeck, Lübeck, Germany.
Arch Neurol. 2011 Jun;68(6):709-16. doi: 10.1001/archneurol.2011.11. Epub 2011 Feb 14.
We provide an update on the state of translational research in movement disorders, using examples of Huntington disease, Parkinson disease, and dystonia. While substantial progress in our understanding of these disorders has been achieved, development of neuroprotective treatments remains an unrealized goal. Here we highlight some of the emerging research areas that show the most promise for translational research in Huntington disease, Parkinson disease, and dystonia. Aetiology and pathogenesis, biomarker directions, and causal treatment opportunities are discussed for each disease, followed by a brief discussion drawing attention to important translational initiatives.
我们以亨廷顿舞蹈症、帕金森病和肌张力障碍为例,介绍运动障碍转化研究的现状。虽然我们对这些疾病的认识已取得重大进展,但神经保护治疗的开发仍是一个未实现的目标。在此,我们重点介绍一些新兴研究领域,这些领域在亨廷顿舞蹈症、帕金森病和肌张力障碍的转化研究中最具潜力。我们将针对每种疾病讨论其病因和发病机制、生物标志物研究方向以及因果治疗机会,随后简要讨论一些重要的转化研究举措。